Tagged senzo
Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test
The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples
Read More
Senzo Secures a $2mm Pre-Series A Financing Led by Bioadvance to Progress Its Breakthrough Lateral Flow Diagnostic Testing Platform for Covid-19, Flu A/B, Tuberculosis, HIV
Funds will be used to bring the Amplified Lateral Flow (ALF) COVID-19 at-home rapid test through regulatory approval and to market, increase manufacturing capabilities, and advance the development of a range of new tests to significantly improve the diagnosis of the world's most prevalent and deadly diseases
Read More
Senzo's Revolutionary Amplified Lateral Flow (ALF) Platform Delivers Rapid COVID-19 Test Exactly Matching PCR Results in 3rd-Party Study by the University of Sheffield
World's first amplified lateral flow rapid test combines the accuracy and early detection of central lab testing with the simplicity, speed, and low cost of traditional lateral flow tests
Read More